Gastrooesophageal cancer
Information
- Disease name
- Gastrooesophageal cancer
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05071053 | Active, not recruiting | Phase 2 | Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer | November 16, 2021 | June 28, 2024 |
| NCT03416244 | Completed | Phase 2 | A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer | February 21, 2018 | November 19, 2021 |
| NCT01135849 | Completed | B-Receptor Signaling in Cardiomyopathy | November 2008 | October 2010 | |
| NCT01980394 | Completed | N/A | Esophageal Stump Washout | May 2004 | December 2013 |
| NCT05965479 | Recruiting | Phase 2 | Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer | April 10, 2024 | April 30, 2028 |
| NCT00767234 | Terminated | Permission to Collect Blood Over Time for Research | August 2008 | October 2011 | |
| NCT01365130 | Terminated | Phase 2 | Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen | June 2011 | August 2013 |
| NCT02884453 | Unknown status | Phase 2 | Proof-of-concept Study of Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma | July 19, 2016 | December 30, 2021 |
| NCT02274012 | Withdrawn | Phase 2 | Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment | May 29, 2014 | August 12, 2015 |